.AstraZeneca has shared an early examine the functionality of its in-house antibody-drug conjugate (...
.After declaring a stage 3 launch based upon favorable midstage end results, iTeos and also GSK are ...
.The FDA needs to be actually even more open as well as joint to let loose a rise in commendations o...
.It is actually an extraordinarily hectic Friday for biotech IPOs, with Zenas BioPharma, MBX and Bic...
.Atea Pharmaceuticals' antiviral has neglected yet another COVID-19 test, yet the biotech still hold...
.Neurocrine Biosciences' schizophrenia program pivot has fallen short. The biotech was not able to d...
.Sanofi has actually brought in a late entrance to the radioligand event, paying for one hundred tho...
.After F2G's initial effort to obtain a new training class of antifungal to market was hindered due ...
.Moderna has sworn to cut R&D costs by $1.1 billion through 2027. The decision to retract the fin...
.Merely four months after Sanofi bet $80 million in upfront cash on Key Therapeutics' losmapimod, th...